Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome
Year: 2025
Type: article
Language: en
Topic: Cancer-related Molecular Pathways
Authors and affiliations:
raw_author_name: Emilie Montellier
raw_affiliation_strings: Université Grenoble Alpes, Inserm 1209, CNRS 5309, Institute for Advanced Biosciences, F38000, Grenoble, France. Electronic address: emilie.montellier@univ-grenoble-alpes.fr
raw_author_name: Olivier Manches
raw_affiliation_strings: Université Grenoble Alpes, Inserm 1209, CNRS 5309, Institute for Advanced Biosciences, F38000, Grenoble, France; EFS, R&D Department, Grenoble, France
raw_author_name: Jonathan Gaucher
raw_affiliation_strings: Grenoble Alpes University, HP2 Laboratory, INSERM U1300, Grenoble Alpes University Hospital, Grenoble, France
raw_author_name: Claire Freycon
raw_affiliation_strings: Department of Pediatric Hematology-Oncology, Grenoble Alpes University Hospital, Grenoble, France
raw_author_name: David Hoyos
raw_affiliation_strings: Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
raw_author_name: Sandrine Blanchet
raw_affiliation_strings: Université Grenoble Alpes, Inserm 1209, CNRS 5309, Institute for Advanced Biosciences, F38000, Grenoble, France
raw_author_name: Murielle Verboom
raw_affiliation_strings: Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany
raw_author_name: Christina M. Dutzmann
raw_affiliation_strings: Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
raw_author_name: Sophie Coutant
raw_affiliation_strings: Univ Rouen Normandie, Inserm U1245, Normandie Univ, CHU Rouen, Department of Genetics, F-76000, Rouen, France
raw_author_name: Jacqueline Bou
raw_affiliation_strings: Univ Rouen Normandie, Inserm U1245, Normandie Univ, CHU Rouen, Department of Genetics, F-76000, Rouen, France
raw_author_name: Bertrand Fin
raw_affiliation_strings: Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), 91057, Evry, France
raw_author_name: Robert Olaso
raw_affiliation_strings: Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), 91057, Evry, France
raw_author_name: Jean-François Deleuze
raw_affiliation_strings: Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), 91057, Evry, France
raw_author_name: Thierry Frébourg
raw_affiliation_strings: Univ Rouen Normandie, Inserm U1245, Normandie Univ, CHU Rouen, Department of Genetics, F-76000, Rouen, France
raw_author_name: Benjamin D. Greenbaum
raw_affiliation_strings: Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Physiology, Biophysics & Systems Biology, Weill Cornell Medicine, Weill Cornell Medical College, New York, NY, USA; The Olayan Center for Cancer Vaccines, Memorial Sloan Kettering Cancer Center, New York, NY, USA
raw_author_name: Arnold J. Levine
raw_affiliation_strings: Simons Center for Systems Biology, Institute for Advanced Study, Princeton, NJ, USA
raw_author_name: Christian P. Kratz
raw_affiliation_strings: Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
raw_author_name: Gaëlle Bougeard
raw_affiliation_strings: Univ Rouen Normandie, Inserm U1245, Normandie Univ, CHU Rouen, Department of Genetics, F-76000, Rouen, France
raw_author_name: Pierre Hainaut
raw_affiliation_strings: Université Grenoble Alpes, Inserm 1209, CNRS 5309, Institute for Advanced Biosciences, F38000, Grenoble, France